ID

34576

Description

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01925755

Link

https://clinicaltrials.gov/show/NCT01925755

Keywords

  1. 1/19/19 1/19/19 -
  2. 9/28/20 9/28/20 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Stroke, NCT01925755

Eligibility Stroke, NCT01925755

  1. StudyEvent: Eligibility
    1. Eligibility Stroke, NCT01925755
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients ≥ 18 years old who start treatment with rivaroxaban
Description

ID.1

Data type

boolean

non-valvular atrial fibrillation is documented in patients' file
Description

ID.2

Data type

boolean

prior tia/stroke history
Description

ID.3

Data type

boolean

tia - more than 72 hours after documented tia
Description

ID.4

Data type

boolean

more than 2 weeks after non-hemorrhagic stroke
Description

ID.5

Data type

boolean

written informed consent
Description

ID.6

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications for use of xarelto® in accordance with approved product label
Description

ID.7

Data type

boolean

previous thromboprophylaxis treatment with anticoagulants prior toby reason of stroke
Description

ID.8

Data type

boolean

/ tia prevention
Description

ID.9

Data type

boolean

any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
Description

ID.10

Data type

boolean

Similar models

Eligibility Stroke, NCT01925755

  1. StudyEvent: Eligibility
    1. Eligibility Stroke, NCT01925755
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male and female patients ≥ 18 years old who start treatment with rivaroxaban
boolean
ID.2
Item
non-valvular atrial fibrillation is documented in patients' file
boolean
ID.3
Item
prior tia/stroke history
boolean
ID.4
Item
tia - more than 72 hours after documented tia
boolean
ID.5
Item
more than 2 weeks after non-hemorrhagic stroke
boolean
ID.6
Item
written informed consent
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
contraindications for use of xarelto® in accordance with approved product label
boolean
ID.8
Item
previous thromboprophylaxis treatment with anticoagulants prior toby reason of stroke
boolean
ID.9
Item
/ tia prevention
boolean
ID.10
Item
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial